FDA
-
-
-
-
-
-
-
NurExone Reports First Quarter 2024 Financial Results and Provides Corporate Update, moving forward with FDA guidelines for the Human Trials
-
-
-
-
-
-
-
NurExone Announces Closing of a Private Placement for Gross Proceeds of Approximately CAD$2 Million
-
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

